{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T09:33:33Z","timestamp":1746524013850,"version":"3.37.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1UH2CA260389","1UH2CA260389","R01CA247479"],"award-info":[{"award-number":["1UH2CA260389","1UH2CA260389","R01CA247479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PC190039","PC200334","PC200334","PC180469"],"award-info":[{"award-number":["PC190039","PC200334","PC200334","PC180469"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007923","name":"University of Wisconsin Carbone Cancer Center","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2021088"],"award-info":[{"award-number":["2021088"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histopathologic diagnosis and classification of cancer plays a critical role in guiding treatment. Advances in next-generation sequencing have ushered in new complementary molecular frameworks. However, existing approaches do not independently assess both site-of-origin (e.g. prostate) and lineage (e.g. adenocarcinoma) and have minimal validation in metastatic disease, where classification is more difficult. Utilizing gradient-boosted machine learning, we developed ATLAS, a pair of separate AI Tumor Lineage and Site-of-origin models from RNA expression data on 8249 tumor samples. We assessed performance independently in 10,376 total tumor samples, including 1490 metastatic samples, achieving an accuracy of 91.4% for cancer site-of-origin and 97.1% for cancer lineage. High confidence predictions (encompassing the majority of cases) were accurate 98\u201399% of the time in both localized and remarkably even in metastatic samples. We also identified emergent properties of our lineage scores for tumor types on which the model was never trained (zero-shot learning). Adenocarcinoma\/sarcoma lineage scores differentiated epithelioid from biphasic\/sarcomatoid mesothelioma. Also, predicted lineage de-differentiation identified neuroendocrine\/small cell tumors and was associated with poor outcomes across tumor types. Our platform-independent single-sample approach can be easily translated to existing RNA-seq platforms. ATLAS can complement and guide traditional histopathologic assessment in challenging situations and tumors of unknown primary.<\/jats:p>","DOI":"10.1038\/s42003-024-05981-5","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:12:19Z","timestamp":1710328339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A platform-independent AI tumor lineage and site (ATLAS) classifier"],"prefix":"10.1038","volume":"7","author":[{"given":"Nicholas R.","family":"Rydzewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-1431","authenticated-orcid":false,"given":"Matthew R.","family":"Chrostek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-5525","authenticated-orcid":false,"given":"Hamza","family":"Bakhtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle T.","family":"Helzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy J.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-7554","authenticated-orcid":false,"given":"John M.","family":"Floberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace C.","family":"Blitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kosoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina N.","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menggang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-8872","authenticated-orcid":false,"given":"Joshua M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-1939","authenticated-orcid":false,"given":"Krishnan R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-2734","authenticated-orcid":false,"given":"Deborah E.","family":"Citrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-0573","authenticated-orcid":false,"given":"Kaitlin E.","family":"Sundling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-6507","authenticated-orcid":false,"given":"Shuang G.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"5981_CR1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jama.2015.1405","volume":"313","author":"JG Elmore","year":"2015","unstructured":"Elmore, J. G. et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA 313, 1122\u20131132 (2015).","journal-title":"JAMA"},{"key":"5981_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/his.12387","volume":"65","author":"KH Allison","year":"2014","unstructured":"Allison, K. H. et al. Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel. Histopathology 65, 240\u2013251 (2014).","journal-title":"Histopathology"},{"key":"5981_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/21681805.2016.1206619","volume":"50","author":"TA Ozkan","year":"2016","unstructured":"Ozkan, T. A. et al. Interobserver variability in Gleason histological grading of prostate cancer. Scand. J. Urol. 50, 420\u2013424 (2016).","journal-title":"Scand. J. Urol."},{"key":"5981_CR4","doi-asserted-by":"publisher","first-page":"e194337","DOI":"10.1001\/jamanetworkopen.2019.4337","volume":"2","author":"DM Metter","year":"2019","unstructured":"Metter, D. M., Colgan, T. J., Leung, S. T., Timmons, C. F. & Park, J. Y. Trends in the US and Canadian pathologist workforces from 2007 to 2017. JAMA Netw. Open 2, e194337 (2019).","journal-title":"JAMA Netw. Open"},{"key":"5981_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-015-0130-0","volume":"8","author":"AM Marquard","year":"2015","unstructured":"Marquard, A. M. et al. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen. BMC Med. Genomics 8, 58 (2015).","journal-title":"BMC Med. Genomics"},{"key":"5981_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13825-8","volume":"11","author":"W Jiao","year":"2020","unstructured":"Jiao, W. et al. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat. Commun. 11, 728 (2020).","journal-title":"Nat. Commun."},{"key":"5981_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamaoncol.2019.3985","volume":"6","author":"A Penson","year":"2020","unstructured":"Penson, A. et al. Development of genome-derived tumor type prediction to inform clinical cancer care. JAMA Oncol. 6, 84\u201391 (2020).","journal-title":"JAMA Oncol."},{"key":"5981_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3389\/fbioe.2020.00701","volume":"8","author":"Y Liang","year":"2020","unstructured":"Liang, Y. et al. A deep learning framework to predict tumor tissue-of-origin based on copy number alteration. Front Bioeng. Biotechnol. 8, 701 (2020).","journal-title":"Front Bioeng. Biotechnol."},{"key":"5981_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","volume":"17","author":"S Moran","year":"2016","unstructured":"Moran, S. et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 17, 1386\u20131395 (2016).","journal-title":"Lancet Oncol."},{"key":"5981_CR10","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.1703577114","volume":"114","author":"X Hao","year":"2017","unstructured":"Hao, X. et al. DNA methylation markers for diagnosis and prognosis of common cancers. Proc. Natl Acad. Sci. USA 114, 7414\u20137419 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5981_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04815-7","volume":"23","author":"NS Eissa","year":"2022","unstructured":"Eissa, N. S., Khairuddin, U. & Yusof, R. A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation. BMC Bioinf. 23, 273 (2022).","journal-title":"BMC Bioinf."},{"key":"5981_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/epi-2021-0477","volume":"14","author":"JM Bae","year":"2022","unstructured":"Bae, J. M. et al. Identification of tissue of origin in cancer of unknown primary using a targeted bisulfite sequencing panel. Epigenomics 14, 615\u2013628 (2022).","journal-title":"Epigenomics"},{"key":"5981_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03362-2","volume":"20","author":"K Chen","year":"2022","unstructured":"Chen, K. et al. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary. J. Transl. Med. 20, 158 (2022).","journal-title":"J. Transl. Med."},{"key":"5981_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1634\/theoncologist.2009-0328","volume":"15","author":"FA Greco","year":"2010","unstructured":"Greco, F. A. et al. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist 15, 500\u2013506 (2010).","journal-title":"Oncologist"},{"key":"5981_CR15","doi-asserted-by":"crossref","unstructured":"Divate, M. et al. Deep learning-based pan-cancer classification model reveals tissue-of-origin specific gene expression signatures. Cancers (Basel) 14, 1185 (2022).","DOI":"10.3390\/cancers14051185"},{"key":"5981_CR16","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s11517-021-02442-7","volume":"59","author":"N Koul","year":"2021","unstructured":"Koul, N. & Manvi, S. S. Framework for classification of cancer gene expression data using Bayesian hyper-parameter optimization. Med. Biol. Eng. Comput. 59, 2353\u20132371 (2021).","journal-title":"Med. Biol. Eng. Comput."},{"key":"5981_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03554-8","volume":"11","author":"SMM Hossain","year":"2021","unstructured":"Hossain, S. M. M., Khatun, L., Ray, S. & Mukhopadhyay, A. Pan-cancer classification by regularized multi-task learning. Sci. Rep. 11, 24252 (2021).","journal-title":"Sci. Rep."},{"key":"5981_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-3906-0","volume":"18","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data. BMC Genomics 18, 508 (2017).","journal-title":"BMC Genomics"},{"key":"5981_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2022.01.001","volume":"114","author":"KF Mahin","year":"2022","unstructured":"Mahin, K. F. et al. PanClassif: improving pan cancer classification of single cell RNA-seq gene expression data using machine learning. Genomics 114, 110264 (2022).","journal-title":"Genomics"},{"key":"5981_CR20","doi-asserted-by":"publisher","first-page":"e192597","DOI":"10.1001\/jamanetworkopen.2019.2597","volume":"2","author":"JK Grewal","year":"2019","unstructured":"Grewal, J. K. et al. Application of a neural network whole transcriptome-based pan-cancer method for diagnosis of primary and metastatic cancers. JAMA Netw. Open 2, e192597 (2019).","journal-title":"JAMA Netw. Open"},{"key":"5981_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103030","volume":"61","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. EBioMedicine 61, 103030 (2020).","journal-title":"EBioMedicine"},{"key":"5981_CR22","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1158\/1078-0432.CCR-12-0920","volume":"18","author":"SE Kerr","year":"2012","unstructured":"Kerr, S. E. et al. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin. Cancer Res. 18, 3952\u20133960 (2012).","journal-title":"Clin. Cancer Res."},{"key":"5981_CR23","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/bib\/bbaa031","volume":"22","author":"Y Shen","year":"2021","unstructured":"Shen, Y. et al. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary. Brief. Bioinform 22, 2106\u20132118 (2021).","journal-title":"Brief. Bioinform"},{"key":"5981_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.2915","volume":"225","author":"M Ferracin","year":"2011","unstructured":"Ferracin, M. et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J. Pathol. 225, 43\u201353 (2011).","journal-title":"J. Pathol."},{"key":"5981_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/biomet\/87.4.954","volume":"87","author":"IK Yeo","year":"2000","unstructured":"Yeo, I. K. & Johnson, R. A. A new family of power transformations to improve normality or symmetry. Biometrika 87, 954\u2013959 (2000).","journal-title":"Biometrika"},{"key":"5981_CR26","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30 (2017)."},{"key":"5981_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"5981_CR28","unstructured":"Palatucci M., Pomerleau D., Hinton G. E., Mitchell T. M. Zero-shot learning with semantic output codes. Adv. Neural Inf. Process. Syst. 22 (2009)."},{"key":"5981_CR29","unstructured":"Weinberg, R. A. The Biology of Cancer. Second edn, 31\u201369 (Garland Science, 2014)."},{"key":"5981_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 (2016).","journal-title":"Nat. Med."},{"key":"5981_CR31","first-page":"273","volume":"2","author":"V Parimi","year":"2014","unstructured":"Parimi, V., Goyal, R., Poropatich, K. & Yang, X. J. Neuroendocrine differentiation of prostate cancer: a review. Am. J. Clin. Exp. Urol. 2, 273\u2013285 (2014).","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"5981_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2559.2005.02047.x","volume":"46","author":"MC Howe","year":"2005","unstructured":"Howe, M. C. et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46, 195\u2013201 (2005).","journal-title":"Histopathology"},{"key":"5981_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin, C. M., Brambilla, E., Faivre-Finn, C. & Sage, J. Small-cell lung cancer. Nat. Rev. Dis. Prim. 7, 3 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"5981_CR34","unstructured":"DeVita, V. T., Lawrence, T. S. & Rosenberg, S. A. Cancer Principles & Practice of Oncology. Eleventh edn, (Wolters Kluwer, 2021)."},{"key":"5981_CR35","doi-asserted-by":"crossref","unstructured":"Gibson, B. A. et al. Communicating Certainty in Pathology Reports. Arch Pathol Lab Med. 146, 886\u2013893 (2022).","DOI":"10.5858\/arpa.2020-0761-OA"},{"key":"5981_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnci\/djy226","volume":"111","author":"W Hsu","year":"2019","unstructured":"Hsu, W. & Elmore, J. G. Shining light into the black box of machine learning. J. Natl Cancer Inst. 111, 877\u2013879 (2019).","journal-title":"J. Natl Cancer Inst."},{"key":"5981_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"A Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360\u2013371 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"5981_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.prp.2014.04.006","volume":"210","author":"SW Lindley","year":"2014","unstructured":"Lindley, S. W., Gillies, E. M. & Hassell, L. A. Communicating diagnostic uncertainty in surgical pathology reports: disparities between sender and receiver. Pathol. Res. Pr. 210, 628\u2013633 (2014).","journal-title":"Pathol. Res. Pr."},{"key":"5981_CR39","doi-asserted-by":"crossref","unstructured":"van Mourik, A. et al. Six-year experience of Australia\u2019s first dedicated cancer of unknown primary clinic. Br. J. Cancer. 129, 301\u2013308 (2023).","DOI":"10.1038\/s41416-023-02254-6"},{"key":"5981_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Cancer Genome Atlas Research, N.","year":"2013","unstructured":"Cancer Genome Atlas Research, N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"5981_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e411 (2018).","journal-title":"Cell"},{"key":"5981_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"5981_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","volume":"37","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. The international cancer genome consortium data portal. Nat. Biotechnol. 37, 367\u2013369 (2019).","journal-title":"Nat. Biotechnol."},{"key":"5981_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"5981_CR45","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"5981_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s43018-020-0050-6","volume":"1","author":"E Pleasance","year":"2020","unstructured":"Pleasance, E. et al. Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nat. Cancer 1, 452\u2013468 (2020).","journal-title":"Nat. Cancer"},{"key":"5981_CR47","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"5981_CR48","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","volume":"183","author":"K Krug","year":"2020","unstructured":"Krug, K. et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell 183, 1436\u20131456.e1431 (2020).","journal-title":"Cell"},{"key":"5981_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11908","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira, B. et al. Erratum: The somatic mutation profiles of 2433 breast cancers refine their genomic and transcriptomic landscapes. Nat. Commun. 7, 11908 (2016).","journal-title":"Nat. Commun."},{"key":"5981_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"5981_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049.e1019 (2019).","journal-title":"Cell"},{"key":"5981_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","volume":"576","author":"FP Barthel","year":"2019","unstructured":"Barthel, F. P. et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576, 112\u2013120 (2019).","journal-title":"Nature"},{"key":"5981_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","volume":"39","author":"LB Wang","year":"2021","unstructured":"Wang, L. B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 39, 509\u2013528.e520 (2021).","journal-title":"Cancer Cell"},{"key":"5981_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225.e235 (2020).","journal-title":"Cell"},{"key":"5981_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41588-019-0569-6","volume":"52","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat. Genet. 52, 177\u2013186 (2020).","journal-title":"Nat. Genet."},{"key":"5981_CR56","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng.2935","volume":"46","author":"DC Lin","year":"2014","unstructured":"Lin, D. C. et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat. Genet. 46, 467\u2013473 (2014).","journal-title":"Nat. Genet."},{"key":"5981_CR57","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031\u20135052.e5026 (2021).","journal-title":"Cell"},{"key":"5981_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"5981_CR59","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685\u2013689 (2012).","journal-title":"Nat. Genet."},{"key":"5981_CR60","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.eururo.2017.08.027","volume":"73","author":"S Ren","year":"2018","unstructured":"Ren, S. et al. Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression. Eur. Urol. 73, 322\u2013339 (2018).","journal-title":"Eur. Urol."},{"key":"5981_CR61","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011.e1018 (2018).","journal-title":"Cancer Cell"},{"key":"5981_CR62","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","volume":"180","author":"Y Dou","year":"2020","unstructured":"Dou, Y. et al. Proteogenomic characterization of endometrial carcinoma. Cell 180, 729\u2013748.e726 (2020).","journal-title":"Cell"},{"key":"5981_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10873-y","volume":"10","author":"BD Robinson","year":"2019","unstructured":"Robinson, B. D. et al. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat. Commun. 10, 2977 (2019).","journal-title":"Nat. Commun."},{"key":"5981_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165, 35\u201344 (2016).","journal-title":"Cell"},{"key":"5981_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000452","volume":"3","author":"M Parry","year":"2018","unstructured":"Parry, M. Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC. ESMO Open 3, e000452 (2018).","journal-title":"ESMO Open"},{"key":"5981_CR66","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","volume":"162","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 162, 454 (2015).","journal-title":"Cell"},{"key":"5981_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"5981_CR68","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199 (2014).","journal-title":"N. Engl. J. Med."},{"key":"5981_CR69","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1158\/0008-5472.CAN-16-0873","volume":"76","author":"SW Um","year":"2016","unstructured":"Um, S. W. et al. Molecular evolution patterns in metastatic lymph nodes reflect the differential treatment response of advanced primary lung cancer. Cancer Res. 76, 6568\u20136576 (2016).","journal-title":"Cancer Res."},{"key":"5981_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nm.4053","volume":"22","author":"A Kumar","year":"2016","unstructured":"Kumar, A. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat. Med. 22, 369\u2013378 (2016).","journal-title":"Nat. Med."},{"key":"5981_CR71","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5981_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015).","journal-title":"Science"},{"key":"5981_CR73","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.eururo.2019.03.020","volume":"76","author":"WS Chen","year":"2019","unstructured":"Chen, W. S. et al. Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer. Eur. Urol. 76, 562\u2013571 (2019).","journal-title":"Eur. Urol."},{"key":"5981_CR74","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2018.10.019","volume":"175","author":"DA Quigley","year":"2018","unstructured":"Quigley, D. A. et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell 175, 889 (2018).","journal-title":"Cell"},{"key":"5981_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47\u201353 (2015).","journal-title":"Nature"},{"key":"5981_CR76","doi-asserted-by":"publisher","first-page":"e1005895","DOI":"10.1371\/journal.pgen.1005895","volume":"12","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Genomic landscape survey identifies SRSF1 as a key oncodriver in small cell lung cancer. PLoS Genet. 12, e1005895 (2016).","journal-title":"PLoS Genet."},{"key":"5981_CR77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.32614\/RJ-2020-013","volume":"12","author":"M Brandon","year":"2020","unstructured":"Brandon, M. & Greenwell, B. C. B. Variable Importance Plots\u2014An Introduction to the vip package. R. J. 12, 343\u2013366 (2020).","journal-title":"R. J."},{"key":"5981_CR78","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1200\/CCI.19.00119","volume":"4","author":"M Ramos","year":"2020","unstructured":"Ramos, M. et al. Multiomic integration of public oncology databases in bioconductor. JCO Clin. Cancer Inf. 4, 958\u2013971 (2020).","journal-title":"JCO Clin. Cancer Inf."},{"key":"5981_CR79","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"5981_CR80","unstructured":"Kuhn, M. & Wickham, H. Tidymodels: a collection of packages for modeling and machine learning using tidyverse principles. First edn, (O'Reilly Media, 2020)."},{"key":"5981_CR81","unstructured":"Kassambara, A. & Kosinski M. survminer: Survival Analysis and Visualization. (2017)."},{"key":"5981_CR82","unstructured":"Nakazawa, M. Practices of Medical and Health Data Analysis using R. (Pearson Education, 2007)."},{"key":"5981_CR83","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1145\/2939672.2939785","volume":"KDD \u201816","author":"T Chen","year":"2016","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. Proc. 22nd ACM SIGKDD Int. Conf. Knowl. Discov. Data Min. KDD \u201816, 785\u2013794 (2016).","journal-title":"Proc. 22nd ACM SIGKDD Int. Conf. Knowl. Discov. Data Min."},{"key":"5981_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010920819831","volume":"45","author":"DJ Hand","year":"2001","unstructured":"Hand, D. J. & Till, R. J. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach. Learn. 45, 171\u2013186 (2001).","journal-title":"Mach. Learn."},{"key":"5981_CR85","doi-asserted-by":"publisher","unstructured":"Rydzewski, N. R. et al. ATLAS. Version 1.0.4. (Zenodo, 2024) https:\/\/doi.org\/10.5281\/zenodo.10703256.","DOI":"10.5281\/zenodo.10703256"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-05981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-05981-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-05981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T15:05:09Z","timestamp":1710601509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-05981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5981"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-05981-5","relation":{},"ISSN":["2399-3642"],"issn-type":[{"type":"electronic","value":"2399-3642"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following authors declare the following competing interests: K.T.H. has a family member that is an employee of Epic Systems; M.L.B. has a family member who is an employee of Luminex; S.G.Z. reports unrelated patents licensed to Veracyte, and that a family member is an employee of Artera and holds stock in Exact Sciences. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}